Target intelligence / Profile preview

Phagocytic and scavenger pathways on antigen-presenting cells

Molecular classification
Pathway, Receptor family, Innate immune component
01

Overview

Phagocytic and scavenger pathways on antigen-presenting cells (APCs) represent a complex network of receptors and intracellular signaling events dedicated to the internalisation of extracellular materials, including pathogens, apoptotic cells, and modified self-molecules (Canton et al., 2013 [PMID: 23928573]). These pathways are primarily mediated by a diverse array of receptors such as scavenger receptors (e.g., MSR1, CD36, MARCO), Fc receptors, and complement receptors expressed on macrophages and dendritic cells (Zani et al., 2015 [PMID: 25871461]). Beyond simple clearance, these pathways are critical for the processing and presentation of antigens to T cells, thereby bridging innate and adaptive immunity (Lim et al., 2011 [PMID: 21904389]). Dysregulation of these pathways is implicated in various pathologies, including atherosclerosis (via foam cell formation), autoimmune diseases (due to defective clearance of apoptotic debris), and cancer (where scavenger receptors can modulate the immunosuppressive tumor microenvironment) (PrabhuDas et al., 2017 [PMID: 29144460]). Therapeutic strategies targeting these pathways often focus on specific receptors to either enhance pathogen clearance or inhibit the uptake of pro-inflammatory ligands, though maintaining systemic immune homeostasis remains a significant challenge (Nimmerjahn & Ravetch, 2008 [PMID: 18193028]).

Other names
Scavenger receptor-mediated endocytosisPhagocytosis and scavenger receptor-mediated uptakeAntigen uptake pathwaysAPC scavenger pathways
02

Mechanism of action

Modulation of receptor-mediated endocytosis, enhancement of apoptotic cell clearance (efferocytosis), or inhibition of ligand binding to prevent foam cell formation and inflammatory signaling.

03

Biological functions

Immune responseAntigen processing and presentationClearance of apoptotic cells (efferocytosis)Pathogen recognition and uptakeLipid metabolism and transport
04

Disease associations

InfectionAtherosclerosisAutoimmunityCancerNeurodegenerative disease
05

Safety considerations

Risk of systemic immunosuppression (Canton et al., 2013 [PMID: 23928573])Impaired efferocytosis leading to secondary necrosis and autoimmunity (Elliott & Ravichandran, 2010 [PMID: 20512134])Disruption of lipid homeostasis and metabolic side effects (Silverstein & Febbraio, 2009 [PMID: 19172134])
06

Interacting drugs

Intravenous immunoglobulin (Nimmerjahn & Ravetch, 2008 [PMID: 18193028])

4 more in the full profile.

07

Biomarkers

Soluble CD163 (sCD163) (Moller et al., 2002 [PMID: 12117688])CD206 (Mannose receptor) expression (Azad et al., 2014 [PMID: 24954695])CD36 surface expression (Handberg et al., 2006 [PMID: 16432030])Soluble CD14 (sCD14) (Shive et al., 2015 [PMID: 25595774])

Beyond the preview

Go deeper on Phagocytic and scavenger pathways on antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phagocytic and scavenger pathways on antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call